Two companies join the battle over Daraprim
December 01, 2015 at 00:01 AM EST
Two companies are taking matters into their own hands to help make an alternative to an expensive drug more readily available to the public.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.